These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35193374)

  • 1. Challenges and Lessons Learned in the Regional Implementation of MISSION-CJ in Drug Treatment Courts.
    Berdine DE; Thomas MC; Kahn LS; Vest BM
    Psychiatr Serv; 2022 Aug; 73(8):950-953. PubMed ID: 35193374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of MISSION-Criminal Justice in a Treatment Court: Preliminary Outcomes Among Individuals With Co-occurring Disorders.
    Pinals DA; Gaba A; Clary KM; Barber J; Reiss J; Smelson D
    Psychiatr Serv; 2019 Nov; 70(11):1044-1048. PubMed ID: 31337322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engaging vulnerable populations in drug treatment court: Six month outcomes from a co-occurring disorder wraparound intervention.
    Shaffer PM; Rodriguez CP; Gaba A; Byrne T; Casey SC; Harter J; Smelson D
    Int J Law Psychiatry; 2021; 76():101700. PubMed ID: 33864989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying strategies to advance equitable implementation of co-occurring mental health and substance use disorder treatment in drug treatment courts: A study protocol.
    Gaba A; LoVette A; Pridgen B; Taylor M; Woodward E; Rosal MC; Anderson M; Smelson D
    J Clin Transl Sci; 2023; 7(1):e80. PubMed ID: 37125066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embedding a Co-occurring Disorders Rehabilitation Intervention in Veterans Courts: A Pilot Study with Male Veterans.
    Smelson DA; Gaba A; Pressman K; Clary KM; Shaffer PM; Pinals DA
    Community Ment Health J; 2020 Jul; 56(5):970-977. PubMed ID: 32006293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of conducting research in drug treatment court settings.
    Belenko S
    Subst Use Misuse; 2002; 37(12-13):1635-64. PubMed ID: 12487237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based treatment and supervision practices for co-occurring mental and substance use disorders in the criminal justice system.
    Peters RH; Young MS; Rojas EC; Gorey CM
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):475-488. PubMed ID: 28375656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile drug treatment courts in the United States: initial lessons learned and issues being addressed.
    Cooper CS
    Subst Use Misuse; 2002; 37(12-13):1689-722. PubMed ID: 12487239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating a Co-occurring Disorders Intervention in Drug Courts: An Open Pilot Trial.
    Smelson D; Farquhar I; Fisher W; Pressman K; Pinals DA; Samek B; Duffy MK; Sawh L
    Community Ment Health J; 2019 Feb; 55(2):222-231. PubMed ID: 29516336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on the drug court model across systems: a process evaluation.
    Wolfe EL; Guydish J; Woods W; Tajima B
    J Psychoactive Drugs; 2004 Sep; 36(3):379-86. PubMed ID: 15559684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining implementation and preliminary performance indicators of veterans treatment courts: The Kentucky experience.
    Shannon LM; Birdwhistell S; Hulbig SK; Jones AJ; Newell J; Payne C
    Eval Program Plann; 2017 Aug; 63():54-66. PubMed ID: 28371669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing drug abuse treatment services in criminal justice settings: Introduction to the CJ-DATS study protocol series.
    Ducharme LJ; Chandler RK; Wiley TR
    Health Justice; 2013 Dec; 1(1):5. PubMed ID: 24707454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment inside the drug treatment court: the who, what, where, and how of treatment services.
    Taxman FS; Bouffard J
    Subst Use Misuse; 2002; 37(12-13):1665-88. PubMed ID: 12487238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating the criminal justice system into mental health service delivery: the worcester diversion experience.
    Grudzinskas AJ; Clayfield JC; Roy-Bujnowski K; Fisher WH; Richardson MH
    Behav Sci Law; 2005; 23(2):277-93. PubMed ID: 15818600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurring disorders in treatment-based courts: results of a national survey.
    Peters RH; Kremling J; Bekman NM; Caudy MS
    Behav Sci Law; 2012; 30(6):800-20. PubMed ID: 22807069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure in the context of substance user interventions: drug treatment courts.
    Cooper C
    Subst Use Misuse; 2012; 47(13-14):1463-5. PubMed ID: 23186442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. North Carolina Specialty Courts, Treatment Access, and the Substance Use Crisis: A Promising but Underfunded Model.
    Easter MM; Swanson JW; Crozier WE; Robertson AG; Garrett BL; Modjadidi K; Swartz MS
    Psychiatr Serv; 2021 Dec; 72(12):1471-1474. PubMed ID: 34139882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six lessons from state physician health programs to promote long-term recovery.
    Dupont RL; Skipper GE
    J Psychoactive Drugs; 2012; 44(1):72-8. PubMed ID: 22641968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological, ethical, and legal considerations in drug court research.
    DeMatteo D; Filone S; Laduke C
    Behav Sci Law; 2011; 29(6):806-20. PubMed ID: 21971950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug courts: a primer for the family physician.
    Lessenger JE; Roper GF
    J Am Board Fam Pract; 2002; 15(4):298-303. PubMed ID: 12150463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.